Mohammed Alsbou

ORCID: 0000-0002-7065-5059
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Pharmacovigilance and Adverse Drug Reactions
  • Pharmaceutical Practices and Patient Outcomes
  • Pharmaceutical studies and practices
  • Dental Research and COVID-19
  • Drug-Induced Adverse Reactions
  • Academic integrity and plagiarism
  • Chemotherapy-related skin toxicity
  • Mitochondrial Function and Pathology
  • Computational Drug Discovery Methods
  • Oral microbiology and periodontitis research
  • Antibiotic Resistance in Bacteria
  • Antibiotic Use and Resistance
  • Healthcare Quality and Management
  • Pharmaceutical Quality and Counterfeiting
  • Bacterial Identification and Susceptibility Testing
  • Patient Safety and Medication Errors
  • Diet and metabolism studies
  • Dental Health and Care Utilization
  • Patient Satisfaction in Healthcare
  • Metabolism and Genetic Disorders

Ajman University
2022-2025

Mutah University
2011-2024

Background/Objectives: The current study aimed to evaluate the oral health self-perception on quality of life in elderly using Geriatric Oral Health Assessment Index (GOHAI) assess impact demographic and factors health-related life. Methods: An observational prospective cross-sectional for entire six-month period was conducted a dental care center United Arab Emirates. principal inclusion criterion is being aged 60 over. GOHAI questionnaire composed 4 domains 12 items that address functional...

10.3390/dj13030123 article EN cc-by Dentistry Journal 2025-03-11

Introduction Pharmacovigilance (PV) also known as drug safety surveillance is the science of enhancing patient through collecting, monitoring, assessing and preventing adverse reactions (ADRs) 1. The objectives PV are to improve public health in relation use

10.13005/bpj/1112 article EN cc-by Biomedical & Pharmacology Journal 2017-03-25

Introduction Pharmacovigilance (PV) is a system to monitor the safety and effectiveness of medicines. The ultimate goals PV are ensure rational safe use medicines improve public health1. World Health Organization (WHO) defines pharmacovigilance as '' scie

10.13005/bpj/965 article EN cc-by Biomedical & Pharmacology Journal 2016-08-21

Background/Objectives: Antimicrobial resistance is considered one of the foremost global public health challenges, and its prevalence increasing. In Jordan, particularly in Al-Karak Governorate, there a lack sufficient data on antimicrobial to make accurate assessments. The main aim current study was evaluate antibiotic trends clinical specimens from 2022 assess patterns. emphasis WHO classification as Access, Watch, Reserved (AWaRe) adopted study. Results: Among Gram-positive bacteria,...

10.3390/antibiotics13121172 article EN cc-by Antibiotics 2024-12-04

ABSTRACT: A national pharmacovigilance database was created recently at the Rational Drug Use and Pharmacovigilance Department Jordan Food Administration (JFDA). This study based on analysis of adverse drug reactions (ADRs) reports submitted to (PV) in from 2010 2014.The aims this were identify most frequently body system classes common ADRs for four major dugs implicated PV include: antineoplastics, immunomodulators, antibiotics analgesics. The affected systems by our skin gastrointestinal...

10.13005/bbra/2477 article EN Biosciences Biotechnology Research Asia 2017-06-25

Background: Leadership is an essential element in creating effective healthcare system that aims to enhance staff satisfaction, improve the productivity and efficiency of teams, minimize conflicts, develop organizational culture committed quality.Objectives: To investigate experience attitudes about impact leadership on organizations among providers United Arab Emirates (UAE).Methods Materials: This cross-sectional study was conducted licensed UAE professionals. A web-based self-administered...

10.1080/20479700.2023.2233190 article EN International Journal of Healthcare Management 2023-07-13

Knowledge, attitude, and practice toward pharmacovigilance (PV) among healthcare providers are strongly associated with reporting of adverse drug reactions (ADRs). This study was conducted to evaluate knowledge, identify barriers for ADR physicians working at public private hospitals in Jordan. using an online questionnaire the Arabic language, designed by members Health Hazard Evaluation Committee Jordan Food Drug Administration (JFDA) between (August 2016 December 2017). The completed...

10.35516/jmj.v56i4.468 article EN Jordan Medical Journal 2022-10-16
Coming Soon ...